TERCONAZOLE

Generic: TERCONAZOLE

Padagis Israel Pharmaceuticals LtdManufacturer
VAGINALRoute
TERCONAZOLEActive Substance
2006-03-17Original Approval

TERCONAZOLE is FDA application ANDA077149, sponsored by PADAGIS ISRAEL. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Class II2022-01-26
Terconazole Vaginal Suppositories, 80 mg, 3 Suppositories with Vaginal Applicator, Rx only, Manufactured by: Cosette Ph

CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage condi

Top Reported Reactions

1
PAIN
95 reports
2
CHRONIC KIDNEY DISEASE
68 reports
3
DRUG INEFFECTIVE
56 reports
4
NAUSEA
50 reports
5
ANXIETY
49 reports
6
HEADACHE
45 reports
7
URINARY TRACT INFECTION
43 reports
8
FATIGUE
39 reports
9
PRODUCT QUALITY ISSUE
39 reports
10
ACUTE KIDNEY INJURY
37 reports